Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.3.4 and removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:17:26.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:54:30.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Minor update to the study page indicating a revision from v3.3.1 to v3.3.2; no substantive changes to study design, inclusion criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:25:29.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed. This update does not modify any study data, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2025-11-24T14:43:37.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The government operating status banner regarding funding lapses was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:52:39.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    No significant changes to core study information were detected; the differences appear to be limited to formatting and layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:16:50.000Z thumbnail image

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.